Mon, July 23, 2018

David Risinger Initiated (AMRX) at Buy and Held Target at $22 on, Jul 23rd, 2018

David Risinger of Morgan Stanley, Initiated "Amneal Pharmaceuticals, Inc." (AMRX) at Buy and Held Target at $22 on, Jul 23rd, 2018.

David has made no other calls on AMRX in the last 4 months.



There is 1 other peer that has a rating on AMRX. Out of the 1 peers that are also analyzing AMRX, 0 agree with David's Rating of Hold.



This is the rating of the analyst that currently disagrees with David


  • David Buck of "B. Riley Securities" Initiated at Strong Buy and Held Target at $26 on, Friday, June 22nd, 2018